Your browser doesn't support javascript.
loading
Clinical outcomes with fixed-duration therapy (UK real-world data) compared with continuous lenalidomide and low-dose dexamethasone therapy (FIRST trial; MM-020) for transplant-ineligible patients with newly-diagnosed multiple myeloma.
Sharpley, Faye A; Djebbari, Faouzi; Fourali, Samih; Kothari, Jaimal; Lynes, John A; McLain-Smith, Susan; Ramasamy, Karthik.
Affiliation
  • Sharpley FA; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Djebbari F; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Fourali S; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Kothari J; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Lynes JA; NIHR Oxford Biomedical Research Centre Blood Theme, Oxford, UK.
  • McLain-Smith S; Celgene Ltd, Uxbridge, UK.
  • Ramasamy K; pH Associates Ltd, Marlow, UK.
Leuk Lymphoma ; 61(3): 732-736, 2020 03.
Article in En | MEDLINE | ID: mdl-31771382
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Type of study: Diagnostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Type of study: Diagnostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Country of publication: